Page 34 - EndoProxy2012_final

SEO Version

endo
|
100 Endo Boulevard
|
Chadds Ford, Pennsylvania 19317
28
For PSUs granted in 2012, TSR performance will be measured relative to the S&P 1500 Health Care Index instead of the
NASDAQ Biotechnology Index, reflecting our continuing transition to a broader healthcare solutions company.
The number of PSUs awarded to each executive is based on a targeted percentage of the executive’s base salary with
the actual number of shares awarded adjusted to between zero and 200% of the target award amount based upon
achievement of pre-determined TSR performance and cumulative net sales goals. PSUs are designed to encourage and
reward our executives for achieving longer-term financial goals as well as meeting or exceeding the relative financial
performance of our industry group.
In February 2012, the Compensation Committee reviewed and approved measures and target performance levels for
the 2012–2014 performance period and awarded PSUs to its NEOs. The performance period for these awards began on
January 1, 2012 and ends on December 31, 2014. Payouts with respect to these PSUs, if any, will be made in shares of
Company common stock in February 2015, following the close of the three-year performance cycle. In determining the
extent to which the pre-set performance measures are met for a given period, the Compensation Committee may exer-
cise its judgment whether to reflect or exclude the impact of changes in accounting principles and extraordinary, unusual
or infrequently occurring events reported in the Company’s public filings.
Holders of PSUs will be entitled to receive a number of
shares of Company common stock as of December 31,
2014 equal to a multiple of the TSR Stock Award based
on the Company’s relative Total Shareholder Return (as
specifically defined below) for the performance period as
compared to the Total Shareholder Return for the per-
formance period of companies comprising the S&P 1500
Health Care Index as of the last day of the performance
period, in accordance with the graph to the left; provided,
however, that, notwithstanding the graph to the left, no
portion of the TSR Stock Award shall vest if the Compa-
ny’s Total Shareholder Return for the performance period
is negative.
“Total Shareholder Return”
shall mean the appreciation of
the Per Share Price during the performance period, plus
any dividends paid on the applicable company’s common
stock during such performance period.
“Per Share Price”
shall mean the average of the closing prices of common shares for the applicable company during the
eighty (80) consecutive trading days ending on the day prior to the applicable measurement date.
Holders of PSUs will be entitled to receive a
number of shares of Company common stock
as of December 31, 2014 equal to a multiple of
the Net Sales Stock Award based on the Com-
pany’s cumulative Net Sales (as specifically
defined below) for the performance period as
compared to the Company’s target Net Sales
in accordance with the graph to the right.
In setting the Company’s cumulative Net
Sales target, the Compensation Commit-
tee considers several factors, including the
Company’s three-year organic sales growth
projections, new product introductions, and
incremental revenues associated with new
business opportunities. For any payout to oc-
cur for the portion of the program related to
cumulative Net Sales, significant Net Sales
growth must be achieved relative to the actual
Net Sales for the year preceding the perfor-
mance period.
“Net Sales”
shall mean the revenues from the Company’s sales (including, but not limited to, sales of the Company’s phar-
maceutical products, devices and services) plus royalties and other payments earned from third parties as a result of
licensing activities and royalties earned on sales of the underlying products, as recognized in accordance with account-
105%
Multiple of the Target N
et
Sales Stock Award
2.00x
1.75x
1.50x
1.25x
1.00x
0.75x
0.50x
0.25x
0.00x
Cumulative Target Net Sales
103%
but
105%
102%
but
103%
101%
but
102%
99%
but
101%
98%
but
99%
97%
but
98%
95%
but
97%
95%
90th
to99th
Multiple of the Target
TSR Stock Award
80th
to89th
70th
to 79th
60th
to69th
50th
to 59th
40th
to49th
Below
40th
2.00x
1.75x
1.50x
1.25x
Percentile Ranking vs. Index
1.00x
0.50x
0.00x